PTCH1 and skin basal cell carcinoma: Resistance mechanisms have been described for both sporadic BCC patients and GS patients who carry PTCH1 germline mutations; in the latter, it has been hypothesized that BCCs in advanced stage would have higher chances of developing resistant mutations.